Evidence map›Paper›PMID 33106476›Full record

ArticleNature communications2020

Two-tier supramolecular encapsulation of small molecules in a protein cage.

Thomas G W Edwardson, Stephan Tetter, Donald Hilvert

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Rapid and automated design of two-component protein nanomaterials using ProteinMPNN.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Article
  12. Review
  13. Post-Assembly Modification of Protein Cages by Ubc9-Mediated Lysine Acylation.Chembiochem : a European journal of chemical biology · 2022
    Article
  14. Article
  15. Protein Assembly by Design.Chemical reviews · 2021
    Review
  16. Triggered Reversible Disassembly of an Engineered Protein Nanocage*.Angewandte Chemie (International ed. in English) · 2021
    Article
  17. Review
  18. Review
  19. A fragment-based protein interface design algorithm for symmetric assemblies.Protein engineering, design & selection : PEDS · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Thomas G W EdwardsonLaboratory of Organic Chemistry, ETH Zurich, 8093, Zurich, Switzerland.ORCID 0000-0001-8661-8036
Stephan TetterLaboratory of Organic Chemistry, ETH Zurich, 8093, Zurich, Switzerland.ORCID 0000-0002-4175-0225
Donald HilvertLaboratory of Organic Chemistry, ETH Zurich, 8093, Zurich, Switzerland. donald.hilvert@org.chem.ethz.ch.ORCID 0000-0002-3941-621X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expanding protein design to include other molecular building blocks has the potential to increase structural complexity and practical utility. Nature often employs hybrid systems, such as clathrin-coated vesicles, lipid droplets, and lipoproteins, which combine biopolymers and lipids to transport a broader range of cargo molecules. To recapitulate the structure and function of such composite compartments, we devised a supramolecular strategy that enables porous protein cages to encapsulate poorly water-soluble small molecule cargo through templated formation of a hydrophobic surfactant-based core. These lipoprotein-like complexes protect their cargo from sequestration by serum proteins and enhance the cellular uptake of fluorescent probes and cytotoxic drugs. This design concept could be applied to other protein cages, surfactant mixtures, and cargo molecules to generate unique hybrid architectures and functional capabilities.

Indexed as

Drug CompoundingDrug Delivery SystemsHumansPorosityProteinsProteins

Identifiers

PMID33106476
PMCPMC7588467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.